Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa
Public ClinicalTrials.gov record NCT02086890. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Modulating Ocular/Retinal Blood Flow and Visual Function in Retinitis Pigmentosa
Study identification
- NCT ID
- NCT02086890
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Nova Southeastern University
- Other
- Enrollment
- 21 participants
Conditions and interventions
Conditions
Interventions
- Electro-acupuncture Device
- Laser Acupuncture Device
- Sham Electro-acupuncture Device
- Sham laser acupuncture Device
- Sham transcorneal electrical stimulation Device
- Transcorneal Electrical Stimulation Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 12, 2014
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2027
- Last update posted
- Feb 26, 2026
2014 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nova Southeastern University; College of Optometry | Fort Lauderdale | Florida | 33328 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02086890, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2026 · Synced May 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02086890 live on ClinicalTrials.gov.